chemical entities NCEs

Related by string. * CHEMICAL . chemicals . CHEMICALS . Chemicals . Chemical : Chemical Engineering . Chemical Weapons Convention . Chemical Brothers . My Chemical Romance / ENTITIES . Entities : affiliated entities . interest entities VIEs . quasi governmental entities . unconsolidated entities / NCES . nces . nce : O nce . o nce . nitric oxide donating NCEs . NCE Diversified Flow Through * *

Related by context. Frequent words. (Click for all words.) 66 NCEs 65 therapeutic monoclonal antibodies 64 Mipomersen 63 Zolinza 63 New Chemical Entities 62 therapeutic modalities 62 epothilone 62 nitric oxide donating 62 daptomycin 62 mAbs 61 preclinical compounds 61 oncology therapeutics 61 ophthalmic diseases 61 antisense drug 61 PEGylated 61 NDDS 61 biopharmaceuticals 60 proteasome inhibitors 60 Amrubicin 60 antifungal agent 60 microRNA therapeutics 60 Addrenex 60 ALN TTR# 60 dermatological diseases 60 therapeutics 59 outlicensing 59 antifungal agents 59 LY# [003] 59 elotuzumab 59 Tranzyme 59 Azedra 59 Suven 59 biotherapeutics 59 Rebif ® 59 antisense drugs 59 therapies 59 MAXY G# 59 Maraviroc 59 immunotherapeutics 59 optical biosensors 58 prophylactic vaccines 58 recombinant vaccines 58 immunologic diseases 58 anti infective 58 Tygacil 58 GEM #S 58 investigational compounds 58 therapeutic antibody 58 CD# antibody [001] 58 antiviral therapies 58 therapeutic antibodies 58 biologic therapies 58 oncolytic viruses 58 CCX# 57 anticancer compounds 57 FoldRx 57 integrase inhibitor 57 myeloproliferative disorders 57 Nexavar ® 57 Onalta 57 biologics 57 Sym# 57 monoclonal antibodies 57 hepatitis C HCV 57 Carfilzomib 57 zileuton 57 carcinoid syndrome 57 amphotericin B 57 immunomodulators 57 exon skipping 57 phase IIb clinical 57 ONTAK 57 TNF alpha inhibitors 57 pancreatic NET 57 anticancer agents 57 Levulan PDT 57 commercializing therapeutic 57 OncoVEX GM CSF 57 BAY #-# 57 ocular diseases 57 Pacira 57 Herceptin trastuzumab 57 Crofelemer 57 dalbavancin 57 anticancer compound 57 chemotherapeutics 57 taxol 57 lupus nephritis 57 superficial bladder cancer 57 peptide therapeutics 57 prodrugs 57 humanized antibody 56 PARP inhibitors 56 Neuradiab 56 calcineurin inhibitors 56 therapeutic peptides 56 antiviral compounds 56 therapeutic proteins 56 squalamine 56 atacicept 56 MEK inhibitor

Back to home page